论文信息 - Final efficacy and safety data, and exploratory molecular profiling from the phase III ALUR study of alectinib versus chemotherapy in crizotinib-pretreated ALK-positive non-small-cell lung cancer - 字舞流文

Final efficacy and safety data, and exploratory molecular profiling from the phase III ALUR study of alectinib versus chemotherapy in crizotinib-pretreated ALK-positive non-small-cell lung cancer

R. Dziadziuszko | J. Mazières | K. Trunzer | J. Wolf | Å. Helland | F. Griesinger | S. Novello | M. Chlistalla | I. Oh | M. Migliorino | A. Wrona | V. Smoljanović | T. Ruf | J. de Castro | A. Cardona | M. R. Migliorino